Argenx Se ARGX
NASDAQ ARGX
$1,033.15 -20.31 (-1.93%)
At close: Sep 4, 2026 · 4:00 PM EDT

Argenx Se (ARGX) Prepaid Assets (2015 - 2026)

Argenx Se's (ARGX) quarterly Prepaid Assets came in at $572.0 million in Q2 2026, down 99.84% on a YoY basis from $362.7 billion in Q2 2025, and up 74.39% quarter-over-quarter from $328.0 million in Q4 2025.

Analysis

Argenx Se (ARGX) Prepaid Assets (2015 - 2026) Analysis & Trends

Argenx Se (ARGX) has reported Prepaid Assets for 12 consecutive years, with $572.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Prepaid Assets fell 99.84% year-over-year to $572.0 million; the trailing twelve-month figure through Jun 2026 stood at $572.0 million (down 99.84% YoY), and the FY2025 full-year result was $328.0 million, up 74.52% from the prior year.
  • Prepaid Assets climbed to $572.0 million in Q2 2026 per ARGX's latest filing, from $328.0 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $362.7 billion in Q2 2025 and bottomed at $76.0 million in Q4 2022.
  • Historically, Prepaid Assets has averaged $40.5 billion across 5 years, with a median of $179.4 million in 2024.
  • The sharpest annual moves came in 2022 and 2025: Prepaid Assets tumbled 99.87% in 2022, then jumped 202059.74% in 2025.
  • Over 5 years, Prepaid Assets stood at $76.0 million in 2022, then soared by 76.36% to $134.1 million in 2023, then soared by 40.18% to $187.9 million in 2024, then soared by 74.52% to $328.0 million in 2025, then surged by 74.39% to $572.0 million in 2026.
  • According to Business Quant data, Prepaid Assets over the past three periods registered $572.0 million, $328.0 million, and $362.7 billion for Q2 2026, Q4 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn
10 BioNTech SE 26.24 Bn 12.58 Bn 10.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 572.00 Mn
Dec 31, 2025 328.00 Mn
Jun 30, 2025 362.72 Bn
Dec 31, 2024 187.95 Mn
Jun 30, 2024 179.42 Mn
Dec 31, 2023 134.07 Mn
Jun 30, 2023 138.83 Mn
Dec 31, 2022 76.02 Mn
Jun 30, 2022 82.31 Mn
Dec 31, 2021 58.95 Bn
Jun 30, 2021 62.40 Mn
Dec 31, 2020 27.12 Bn
Jun 30, 2020 11.97 Mn
Dec 31, 2019 9.99 Mn
Jun 30, 2019 9.36 Mn
Dec 31, 2018 3.42 Mn
Jun 30, 2018 5.63 Mn
Dec 31, 2017 2.75 Mn
Jun 30, 2017 2.59 Mn
Dec 31, 2016 2.32 Mn